PALO ALTO, Calif., Oct. 26, 2016 /PRNewswire/ -- Science Exchange, the leading marketplace for scientific research, is excited to announce that Christopher L. Crucitti, MS, has joined the company as Chief Commercial Officer.
Crucitti will be responsible for leading the commercial functions and strategy of Science Exchange, as the company builds upon its industry leading position as the platform of choice for efficient ordering of outsourced scientific services.
"I am extremely excited to be part of this industry leading organization, fueled by a truly transformative platform whose sole purpose is to accelerate breakthrough research. The notion of providing the scientific community with efficient access to a diverse network of qualified partners under a single relationship immediately resonated with me, and I am eager to work with this exceptional team in delivering to our customers and partners globally," Crucitti said.
Crucitti brings significant senior executive level experience and has led commercial, business development, and sales teams to drive significant revenue growth at several contract research organizations (CROs). He joins Science Exchange from Worldwide Clinical Trials, having served as EVP of Global Business Development for their late phase clinical business, where over a five-year period he supported >20% growth in bookings year-on-year. Prior to Worldwide Clinical Trials, he has held various senior level positions in commercial leadership within the CRO space including technology, consulting, strategic resourcing, clinical development and R&D.
"I am thrilled to announce that Chris Crucitti has joined the executive leadership team of Science Exchange as CCO. This key hire is a reflection of the maturing of Science Exchange's enterprise business. We are excited to scale our commercial team to support the R&D programs of our global clients. Science Exchange is proud to provide a world class platform and service for procuring scientific services from our marketplace of 3000+ service providers. The addition of Chris to the senior leadership of our organization indicates Science Exchange's commitment to our continued growth," said Elizabeth Iorns, CEO of Science Exchange.
About Science Exchange:
Science Exchange is the world's leading marketplace for outsourced research. Science Exchange provides an efficient procure-to-pay platform for ordering services from the world's largest network of scientific service providers. Through Science Exchange, clients gain access to 3000+ qualified service providers, all with pre-established contracts in place that protect client intellectual property and confidentiality. This increases scientists access to innovation and significantly improves their productivity because they are freed up from the administrative tasks and delays associated with sourcing, establishing and managing supplier contracts.
At an organizational level, the Science Exchange enterprise program enables organizations to consolidate the long tail of research outsourcing spend into a single strategic supplier relationship driving significant efficiency and cost savings. To date, Science Exchange has raised over $30 million from Maverick Capital Ventures, Union Square Ventures, Index Ventures, OATV, the YC Continuity Fund, and others. For more information visit www.scienceexchange.com.
SOURCE Science Exchange